Načítá se...

Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction

AIMS: Besides regulating calcium‐phosphate metabolism, fibroblast growth factor 23 (FGF‐23) has been associated with incident heart failure (HF) and left ventricular hypertrophy. However, data about FGF‐23 in HF and preserved ejection fraction (HFpEF) remain limited. The aim of this study was to ass...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:ESC Heart Fail
Hlavní autoři: Roy, Clotilde, Lejeune, Sibille, Slimani, Alisson, de Meester, Christophe, Ahn AS, Sylvie A., Rousseau, Michel F., Mihaela, Amzulescu, Ginion, Audrey, Ferracin, Benjamin, Pasquet, Agnès, Vancraeynest, David, Beauloye, Christophe, Vanoverschelde, Jean‐Louis, Horman, Sandrine, Gruson, Damien, Gerber, Bernhard L., Pouleur, Anne‐Catherine
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7524237/
https://ncbi.nlm.nih.gov/pubmed/32578967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12816
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!